Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients
NCT01636778
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
DRUG:
SB-497115-GR
Sponsor
GlaxoSmithKline